Items related to Targeted Radionuclide Tumor Therapy: Biological Aspects
The ambition of the editors of this volume is to enable deeper insights into the process of improving targeted radionuclide therapy. They believe that the time has now come when targeted therapy can soon be added to standard oncology treatment regimens.
"synopsis" may belong to another edition of this title.
From the Back Cover:
Review:
The last three decades have provided opportunities to explore the potential of treating malignant diseases with antibodies or other targeting molecules labelled with nuclides. The expanding array of new targeting molecules (recombinant antibodies or peptides) may increase the therapeutic efficacy. The title of this book "Targeted Radionuclide Tumor Therapy – Biological aspects" was selected to reinforce the concept that a major focus was devoted to understanding the biological effects of targeting and radiation. Furthermore, our rapidly expanding knowledge of low dose-rate effects, different types of cell death, autosensitization and the increasingly likely existence of cancer stem cells suggests to us that even more efficient approaches in targeting might be possible in the future.
The development of targeted therapy is a true multidisciplinary enterprise involving physician scientists from the fields of nuclear medicine, radiation therapy, diagnostic radiology, surgery, gynaecology, pathology and medical oncology/haematology. It also involves many preclinical scientists working with experimental animal models, immunochemistry, recombinant antibody technologies, radiochemistry, radiation physics and basic cell biology.
It is the ambition of the editors to enable deeper insights in the process of improving targeted therapy. We believe that the time now has come when targeted therapy can soon be added to standard oncology treatment regimens.
From the reviews:
"This book is devoted to understanding the biological aspects of targeted radiotherapy and discusses in depth the various targeting agents as well as the radiopharmaceuticals used in targeted therapy. ... Physicians, physicians in training, and physicists who use radionuclide targeted agents in the specialties of radiation oncology, medical oncology, and nuclear medicine are the intended audience. ... Overall this is a very informative book for physicians particularly interested in the biological aspects of targeted radiotherapy." (James G. Douglas, Doody’s Review Service, November, 2009)
"About this title" may belong to another edition of this title.
- PublisherSpringer
- Publication date2010
- ISBN 10 9048179564
- ISBN 13 9789048179565
- BindingPaperback
- Number of pages416
- EditorStigbrand Torgny, Carlsson Jorgen, Adams Gregory P.
Buy New
Learn more about this copy
US$ 186.96
Shipping:
US$ 52.75
From Germany to U.S.A.
Top Search Results from the AbeBooks Marketplace
Seller Image
Targeted Radionuclide Tumor Therapy
Published by
Springer Netherlands
(2010)
ISBN 10: 9048179564
ISBN 13: 9789048179565
New
Kartoniert / Broschiert
Quantity: > 20
Seller:
Rating
Book Description Kartoniert / Broschiert. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Focus on biological effects of targeted radionuclide therapyComprehensive presentation of different mechanisms of tumor cell deathUp-to-date presentation of new targeting agentsSummaries of present state of clinical applications of t. Seller Inventory # 5821790
Buy New
US$ 186.96
Convert currency
Seller Image
Targeted Radionuclide Tumor Therapy
Published by
Springer Netherlands Okt 2010
(2010)
ISBN 10: 9048179564
ISBN 13: 9789048179565
New
Taschenbuch
Quantity: 2
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The last three decades have provided opportunities to explore the potential of treating malignant diseases with antibodies or other targeting molecules labelled with nuclides. While considerable advances have been reported, there is still a signi- cant amount of work left to accomplish before our ambitions can be achieved. It now seems timely to review the accomplishments achieved to date and to clarify the challenges that remain. The choice of radionuclide, the conjugation p- cedure employed, and the selection of suitable targets were early issues that were faced by our field that still persist, however we can now tackle these obstacles with significantly better insight. The expanding array of new targeting molecules (recombinant antibodies, peptides and agents based upon alternate scaffolds) may increase the therapeutic efficacy or even modify the radiation sensitivity of the targeted tumor cell. The title of this book 'Targeted Radionuclide Tumour Therapy - Biological Aspects' was selected to reinforce the concept that a major focus of this volume was devoted to understanding the biological effects of targeting and radiation. These important issues have not previously been the primary focus in this context. Furthermore, our rapidly expanding knowledge of different types of cell death and the increasingly likely existence of cancer stem cells suggests to us that even more efficient approaches in targeting might be possible in the future. 416 pp. Englisch. Seller Inventory # 9789048179565
Buy New
US$ 221.78
Convert currency
Seller Image
Targeted Radionuclide Tumor Therapy : Biological Aspects
Published by
Springer Netherlands
(2010)
ISBN 10: 9048179564
ISBN 13: 9789048179565
New
Taschenbuch
Quantity: 1
Seller:
Rating
Book Description Taschenbuch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - The last three decades have provided opportunities to explore the potential of treating malignant diseases with antibodies or other targeting molecules labelled with nuclides. While considerable advances have been reported, there is still a signi- cant amount of work left to accomplish before our ambitions can be achieved. It now seems timely to review the accomplishments achieved to date and to clarify the challenges that remain. The choice of radionuclide, the conjugation p- cedure employed, and the selection of suitable targets were early issues that were faced by our field that still persist, however we can now tackle these obstacles with significantly better insight. The expanding array of new targeting molecules (recombinant antibodies, peptides and agents based upon alternate scaffolds) may increase the therapeutic efficacy or even modify the radiation sensitivity of the targeted tumor cell. The title of this book 'Targeted Radionuclide Tumour Therapy - Biological Aspects' was selected to reinforce the concept that a major focus of this volume was devoted to understanding the biological effects of targeting and radiation. These important issues have not previously been the primary focus in this context. Furthermore, our rapidly expanding knowledge of different types of cell death and the increasingly likely existence of cancer stem cells suggests to us that even more efficient approaches in targeting might be possible in the future. Seller Inventory # 9789048179565
Buy New
US$ 225.27
Convert currency
Stock Image
Targeted Radionuclide Tumor Therapy: Biological Aspects
Seller:
Rating
Book Description Paperback. Condition: Brand New. 416 pages. 9.00x6.00x0.98 inches. In Stock. Seller Inventory # zk9048179564
Buy New
US$ 309.90
Convert currency